返回
M
Meiji Pharmaceutical University
学者数893
论文数644
被引数402
关联论文 (634)
发表时间
Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium-glucose cotransporter-2 inhibitors?临床指南中强调的治疗选择因素——慢性肾脏病、心血管疾病和心力衰竭——在钠-葡萄糖协同转运蛋白-2抑制剂给药期间是否增加了尿路感染的风险?

